1. Home
  2. MBVI vs VSTM Comparison

MBVI vs VSTM Comparison

Compare MBVI & VSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MBVI

M3-Brigade Acquisition VI Corp. Class A Ordinary Shares

N/A

Current Price

$10.14

Market Cap

438.1M

Sector

N/A

ML Signal

N/A

Logo Verastem Inc.

VSTM

Verastem Inc.

HOLD

Current Price

$3.58

Market Cap

470.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MBVI
VSTM
Founded
2025
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
438.1M
470.7M
IPO Year
N/A
2011

Fundamental Metrics

Financial Performance
Metric
MBVI
VSTM
Price
$10.14
$3.58
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$16.50
AVG Volume (30 Days)
37.7K
2.4M
Earning Date
01-01-0001
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
17.49
EPS
N/A
N/A
Revenue
N/A
$30,914,000.00
Revenue This Year
N/A
$282.64
Revenue Next Year
N/A
$72.25
P/E Ratio
N/A
N/A
Revenue Growth
N/A
209.14
52 Week Low
$9.99
$3.43
52 Week High
$10.18
$11.25

Technical Indicators

Market Signals
Indicator
MBVI
VSTM
Relative Strength Index (RSI) 57.90 36.73
Support Level $9.99 $3.55
Resistance Level $10.18 $4.48
Average True Range (ATR) 0.01 0.31
MACD -0.00 0.01
Stochastic Oscillator 33.33 15.58

Price Performance

Historical Comparison
MBVI
VSTM

About MBVI M3-Brigade Acquisition VI Corp. Class A Ordinary Shares

M3-Brigade Acquisition VI Corp is a newly incorporated blank check company.

About VSTM Verastem Inc.

Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.

Share on Social Networks: